index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Long noncoding RNA DMD Centronuclear myopathy Molecular Sequence Data Delivery Cell Biology Dystrophin central domain DMO Multi resolution modeling CaVβs Immunoglobulin Fc Fragments/pharmacology Dystrophy LKB1 Dystrophie Musculaire de Duchenne DMD Inbred mdx Animals Becker muscular dystrophy Homeostasis Molecular docking Becker BMD muscular dystrophy Antisense oligonucleotides Exon skipping Inbred C57BL Muscle Gene expression Male Muscle Biology Myogenesis Animal/physiopathology Dystrophie Musculaire de Becker BMD Multi exon skipping Muscular Dystrophy Morphogenesis Base Sequence Cachexia Activin Receptors Cells Duchenne DMD dystrophy MES Mice Muscle development Dystrophine Cell homeostasis Muscles/physiopathology Humans Muscular dystrophy Diseases Multiresolution modeling Epigenetics Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Calcium Channels Hepatocellular carcinoma Duchenne muscular dystrophy DMD Dystrophin-EGFP Cultured Hear Allele‐specific silencing therapy Human Umbilical Vein Endothelial Cells Cardiomyopathy LncARN Mdx mouse Genomic Calcium BMD CTNNB1 L-Type Gene modifiers Energy Metabolism/drug effects Autophagy Clinical trials Becker muscular dystrophy BMD Cardiomyopathie LncRNA Muscular Atrophy CD38 Muscle Strength Inhibitors Long QT Génomique DHPR α1S Mitochondrial fission NAD+ Myotendinous junction Duchenne muscular dystrophy Invivo Skeletal muscle Dystrophin Metabolism Drp1 MiARN Liver Gene Expression Regulation/drug effects Cell Line Dynamin 2 Knockout Ex-vivo Modificateurs de gènes NNOS Dystrophie musculaire de Becker CaV subunits